0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Delirium Treatment Drugs Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-34P16332
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Delirium Treatment Drugs Market Research Report 2024
BUY CHAPTERS

Global Delirium Treatment Drugs Market Research Report 2025

Code: QYRE-Auto-34P16332
Report
September 2025
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Delirium Treatment Drugs Market Size

The global market for Delirium Treatment Drugs was valued at US$ 296 million in the year 2024 and is projected to reach a revised size of US$ 451 million by 2031, growing at a CAGR of 6.3% during the forecast period.

Delirium Treatment Drugs Market

Delirium Treatment Drugs Market

North American market for Delirium Treatment Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Delirium Treatment Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Delirium Treatment Drugs include Mylan N.V., Pfizer Inc., Novartis AG, Gala BioPharma Ltd., Teva pharmaceuticals, Dr Franz Kohler Chemie GmbH, Bristol-Myers Squibb, Regenstrief Institute Inc, Fraser Health, Otsuka Pharmaceutical Co. Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Delirium Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Delirium Treatment Drugs.
The Delirium Treatment Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Delirium Treatment Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Delirium Treatment Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Delirium Treatment Drugs Market Report

Report Metric Details
Report Name Delirium Treatment Drugs Market
Accounted market size in year US$ 296 million
Forecasted market size in 2031 US$ 451 million
CAGR 6.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Oral
  • Injection
  • Others
Segment by Application
  • Hospitals
  • Clinics
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Mylan N.V., Pfizer Inc., Novartis AG, Gala BioPharma Ltd., Teva pharmaceuticals, Dr Franz Kohler Chemie GmbH, Bristol-Myers Squibb, Regenstrief Institute Inc, Fraser Health, Otsuka Pharmaceutical Co. Ltd., Zydus Cadila
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Delirium Treatment Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Delirium Treatment Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Delirium Treatment Drugs Market growing?

Ans: The Delirium Treatment Drugs Market witnessing a CAGR of 6.3% during the forecast period 2025-2031.

What is the Delirium Treatment Drugs Market size in 2031?

Ans: The Delirium Treatment Drugs Market size in 2031 will be US$ 451 million.

Who are the main players in the Delirium Treatment Drugs Market report?

Ans: The main players in the Delirium Treatment Drugs Market are Mylan N.V., Pfizer Inc., Novartis AG, Gala BioPharma Ltd., Teva pharmaceuticals, Dr Franz Kohler Chemie GmbH, Bristol-Myers Squibb, Regenstrief Institute Inc, Fraser Health, Otsuka Pharmaceutical Co. Ltd., Zydus Cadila

What are the Application segmentation covered in the Delirium Treatment Drugs Market report?

Ans: The Applications covered in the Delirium Treatment Drugs Market report are Hospitals, Clinics

What are the Type segmentation covered in the Delirium Treatment Drugs Market report?

Ans: The Types covered in the Delirium Treatment Drugs Market report are Oral, Injection, Others

1 Delirium Treatment Drugs Market Overview
1.1 Product Definition
1.2 Delirium Treatment Drugs by Type
1.2.1 Global Delirium Treatment Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Oral
1.2.3 Injection
1.2.4 Others
1.3 Delirium Treatment Drugs by Application
1.3.1 Global Delirium Treatment Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Delirium Treatment Drugs Market Size Estimates and Forecasts
1.4.1 Global Delirium Treatment Drugs Revenue 2020-2031
1.4.2 Global Delirium Treatment Drugs Sales 2020-2031
1.4.3 Global Delirium Treatment Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Delirium Treatment Drugs Market Competition by Manufacturers
2.1 Global Delirium Treatment Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Delirium Treatment Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Delirium Treatment Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Delirium Treatment Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Delirium Treatment Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Delirium Treatment Drugs, Product Type & Application
2.7 Global Key Manufacturers of Delirium Treatment Drugs, Date of Enter into This Industry
2.8 Global Delirium Treatment Drugs Market Competitive Situation and Trends
2.8.1 Global Delirium Treatment Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Delirium Treatment Drugs Players Market Share by Revenue
2.8.3 Global Delirium Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Delirium Treatment Drugs Market Scenario by Region
3.1 Global Delirium Treatment Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Delirium Treatment Drugs Sales by Region: 2020-2031
3.2.1 Global Delirium Treatment Drugs Sales by Region: 2020-2025
3.2.2 Global Delirium Treatment Drugs Sales by Region: 2026-2031
3.3 Global Delirium Treatment Drugs Revenue by Region: 2020-2031
3.3.1 Global Delirium Treatment Drugs Revenue by Region: 2020-2025
3.3.2 Global Delirium Treatment Drugs Revenue by Region: 2026-2031
3.4 North America Delirium Treatment Drugs Market Facts & Figures by Country
3.4.1 North America Delirium Treatment Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Delirium Treatment Drugs Sales by Country (2020-2031)
3.4.3 North America Delirium Treatment Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Delirium Treatment Drugs Market Facts & Figures by Country
3.5.1 Europe Delirium Treatment Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Delirium Treatment Drugs Sales by Country (2020-2031)
3.5.3 Europe Delirium Treatment Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Delirium Treatment Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Delirium Treatment Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Delirium Treatment Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Delirium Treatment Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Delirium Treatment Drugs Market Facts & Figures by Country
3.7.1 Latin America Delirium Treatment Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Delirium Treatment Drugs Sales by Country (2020-2031)
3.7.3 Latin America Delirium Treatment Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Delirium Treatment Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Delirium Treatment Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Delirium Treatment Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Delirium Treatment Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Delirium Treatment Drugs Sales by Type (2020-2031)
4.1.1 Global Delirium Treatment Drugs Sales by Type (2020-2025)
4.1.2 Global Delirium Treatment Drugs Sales by Type (2026-2031)
4.1.3 Global Delirium Treatment Drugs Sales Market Share by Type (2020-2031)
4.2 Global Delirium Treatment Drugs Revenue by Type (2020-2031)
4.2.1 Global Delirium Treatment Drugs Revenue by Type (2020-2025)
4.2.2 Global Delirium Treatment Drugs Revenue by Type (2026-2031)
4.2.3 Global Delirium Treatment Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Delirium Treatment Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Delirium Treatment Drugs Sales by Application (2020-2031)
5.1.1 Global Delirium Treatment Drugs Sales by Application (2020-2025)
5.1.2 Global Delirium Treatment Drugs Sales by Application (2026-2031)
5.1.3 Global Delirium Treatment Drugs Sales Market Share by Application (2020-2031)
5.2 Global Delirium Treatment Drugs Revenue by Application (2020-2031)
5.2.1 Global Delirium Treatment Drugs Revenue by Application (2020-2025)
5.2.2 Global Delirium Treatment Drugs Revenue by Application (2026-2031)
5.2.3 Global Delirium Treatment Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Delirium Treatment Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Mylan N.V.
6.1.1 Mylan N.V. Company Information
6.1.2 Mylan N.V. Description and Business Overview
6.1.3 Mylan N.V. Delirium Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Mylan N.V. Delirium Treatment Drugs Product Portfolio
6.1.5 Mylan N.V. Recent Developments/Updates
6.2 Pfizer Inc.
6.2.1 Pfizer Inc. Company Information
6.2.2 Pfizer Inc. Description and Business Overview
6.2.3 Pfizer Inc. Delirium Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer Inc. Delirium Treatment Drugs Product Portfolio
6.2.5 Pfizer Inc. Recent Developments/Updates
6.3 Novartis AG
6.3.1 Novartis AG Company Information
6.3.2 Novartis AG Description and Business Overview
6.3.3 Novartis AG Delirium Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Novartis AG Delirium Treatment Drugs Product Portfolio
6.3.5 Novartis AG Recent Developments/Updates
6.4 Gala BioPharma Ltd.
6.4.1 Gala BioPharma Ltd. Company Information
6.4.2 Gala BioPharma Ltd. Description and Business Overview
6.4.3 Gala BioPharma Ltd. Delirium Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Gala BioPharma Ltd. Delirium Treatment Drugs Product Portfolio
6.4.5 Gala BioPharma Ltd. Recent Developments/Updates
6.5 Teva pharmaceuticals
6.5.1 Teva pharmaceuticals Company Information
6.5.2 Teva pharmaceuticals Description and Business Overview
6.5.3 Teva pharmaceuticals Delirium Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Teva pharmaceuticals Delirium Treatment Drugs Product Portfolio
6.5.5 Teva pharmaceuticals Recent Developments/Updates
6.6 Dr Franz Kohler Chemie GmbH
6.6.1 Dr Franz Kohler Chemie GmbH Company Information
6.6.2 Dr Franz Kohler Chemie GmbH Description and Business Overview
6.6.3 Dr Franz Kohler Chemie GmbH Delirium Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Dr Franz Kohler Chemie GmbH Delirium Treatment Drugs Product Portfolio
6.6.5 Dr Franz Kohler Chemie GmbH Recent Developments/Updates
6.7 Bristol-Myers Squibb
6.7.1 Bristol-Myers Squibb Company Information
6.7.2 Bristol-Myers Squibb Description and Business Overview
6.7.3 Bristol-Myers Squibb Delirium Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Bristol-Myers Squibb Delirium Treatment Drugs Product Portfolio
6.7.5 Bristol-Myers Squibb Recent Developments/Updates
6.8 Regenstrief Institute Inc
6.8.1 Regenstrief Institute Inc Company Information
6.8.2 Regenstrief Institute Inc Description and Business Overview
6.8.3 Regenstrief Institute Inc Delirium Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Regenstrief Institute Inc Delirium Treatment Drugs Product Portfolio
6.8.5 Regenstrief Institute Inc Recent Developments/Updates
6.9 Fraser Health
6.9.1 Fraser Health Company Information
6.9.2 Fraser Health Description and Business Overview
6.9.3 Fraser Health Delirium Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Fraser Health Delirium Treatment Drugs Product Portfolio
6.9.5 Fraser Health Recent Developments/Updates
6.10 Otsuka Pharmaceutical Co. Ltd.
6.10.1 Otsuka Pharmaceutical Co. Ltd. Company Information
6.10.2 Otsuka Pharmaceutical Co. Ltd. Description and Business Overview
6.10.3 Otsuka Pharmaceutical Co. Ltd. Delirium Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Otsuka Pharmaceutical Co. Ltd. Delirium Treatment Drugs Product Portfolio
6.10.5 Otsuka Pharmaceutical Co. Ltd. Recent Developments/Updates
6.11 Zydus Cadila
6.11.1 Zydus Cadila Company Information
6.11.2 Zydus Cadila Description and Business Overview
6.11.3 Zydus Cadila Delirium Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Zydus Cadila Delirium Treatment Drugs Product Portfolio
6.11.5 Zydus Cadila Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Delirium Treatment Drugs Industry Chain Analysis
7.2 Delirium Treatment Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Delirium Treatment Drugs Production Mode & Process Analysis
7.4 Delirium Treatment Drugs Sales and Marketing
7.4.1 Delirium Treatment Drugs Sales Channels
7.4.2 Delirium Treatment Drugs Distributors
7.5 Delirium Treatment Drugs Customer Analysis
8 Delirium Treatment Drugs Market Dynamics
8.1 Delirium Treatment Drugs Industry Trends
8.2 Delirium Treatment Drugs Market Drivers
8.3 Delirium Treatment Drugs Market Challenges
8.4 Delirium Treatment Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Delirium Treatment Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Delirium Treatment Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Delirium Treatment Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Delirium Treatment Drugs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Delirium Treatment Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Delirium Treatment Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Delirium Treatment Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Delirium Treatment Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Delirium Treatment Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Delirium Treatment Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Delirium Treatment Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Delirium Treatment Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Delirium Treatment Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Delirium Treatment Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Delirium Treatment Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Delirium Treatment Drugs Sales by Region (2020-2025) & (K Units)
 Table 18. Global Delirium Treatment Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Delirium Treatment Drugs Sales by Region (2026-2031) & (K Units)
 Table 20. Global Delirium Treatment Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Delirium Treatment Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Delirium Treatment Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Delirium Treatment Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Delirium Treatment Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Delirium Treatment Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Delirium Treatment Drugs Sales by Country (2020-2025) & (K Units)
 Table 27. North America Delirium Treatment Drugs Sales by Country (2026-2031) & (K Units)
 Table 28. North America Delirium Treatment Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Delirium Treatment Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Delirium Treatment Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Delirium Treatment Drugs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Delirium Treatment Drugs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Delirium Treatment Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Delirium Treatment Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Delirium Treatment Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Delirium Treatment Drugs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Delirium Treatment Drugs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Delirium Treatment Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Delirium Treatment Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Delirium Treatment Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Delirium Treatment Drugs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Delirium Treatment Drugs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Delirium Treatment Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Delirium Treatment Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Delirium Treatment Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Delirium Treatment Drugs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Delirium Treatment Drugs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Delirium Treatment Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Delirium Treatment Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Delirium Treatment Drugs Sales (K Units) by Type (2020-2025)
 Table 51. Global Delirium Treatment Drugs Sales (K Units) by Type (2026-2031)
 Table 52. Global Delirium Treatment Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Delirium Treatment Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Delirium Treatment Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Delirium Treatment Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Delirium Treatment Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Delirium Treatment Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Delirium Treatment Drugs Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Delirium Treatment Drugs Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Delirium Treatment Drugs Sales (K Units) by Application (2020-2025)
 Table 61. Global Delirium Treatment Drugs Sales (K Units) by Application (2026-2031)
 Table 62. Global Delirium Treatment Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Delirium Treatment Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Delirium Treatment Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Delirium Treatment Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Delirium Treatment Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Delirium Treatment Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Delirium Treatment Drugs Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Delirium Treatment Drugs Price (US$/Unit) by Application (2026-2031)
 Table 70. Mylan N.V. Company Information
 Table 71. Mylan N.V. Description and Business Overview
 Table 72. Mylan N.V. Delirium Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Mylan N.V. Delirium Treatment Drugs Product
 Table 74. Mylan N.V. Recent Developments/Updates
 Table 75. Pfizer Inc. Company Information
 Table 76. Pfizer Inc. Description and Business Overview
 Table 77. Pfizer Inc. Delirium Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Pfizer Inc. Delirium Treatment Drugs Product
 Table 79. Pfizer Inc. Recent Developments/Updates
 Table 80. Novartis AG Company Information
 Table 81. Novartis AG Description and Business Overview
 Table 82. Novartis AG Delirium Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Novartis AG Delirium Treatment Drugs Product
 Table 84. Novartis AG Recent Developments/Updates
 Table 85. Gala BioPharma Ltd. Company Information
 Table 86. Gala BioPharma Ltd. Description and Business Overview
 Table 87. Gala BioPharma Ltd. Delirium Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Gala BioPharma Ltd. Delirium Treatment Drugs Product
 Table 89. Gala BioPharma Ltd. Recent Developments/Updates
 Table 90. Teva pharmaceuticals Company Information
 Table 91. Teva pharmaceuticals Description and Business Overview
 Table 92. Teva pharmaceuticals Delirium Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Teva pharmaceuticals Delirium Treatment Drugs Product
 Table 94. Teva pharmaceuticals Recent Developments/Updates
 Table 95. Dr Franz Kohler Chemie GmbH Company Information
 Table 96. Dr Franz Kohler Chemie GmbH Description and Business Overview
 Table 97. Dr Franz Kohler Chemie GmbH Delirium Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Dr Franz Kohler Chemie GmbH Delirium Treatment Drugs Product
 Table 99. Dr Franz Kohler Chemie GmbH Recent Developments/Updates
 Table 100. Bristol-Myers Squibb Company Information
 Table 101. Bristol-Myers Squibb Description and Business Overview
 Table 102. Bristol-Myers Squibb Delirium Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Bristol-Myers Squibb Delirium Treatment Drugs Product
 Table 104. Bristol-Myers Squibb Recent Developments/Updates
 Table 105. Regenstrief Institute Inc Company Information
 Table 106. Regenstrief Institute Inc Description and Business Overview
 Table 107. Regenstrief Institute Inc Delirium Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Regenstrief Institute Inc Delirium Treatment Drugs Product
 Table 109. Regenstrief Institute Inc Recent Developments/Updates
 Table 110. Fraser Health Company Information
 Table 111. Fraser Health Description and Business Overview
 Table 112. Fraser Health Delirium Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Fraser Health Delirium Treatment Drugs Product
 Table 114. Fraser Health Recent Developments/Updates
 Table 115. Otsuka Pharmaceutical Co. Ltd. Company Information
 Table 116. Otsuka Pharmaceutical Co. Ltd. Description and Business Overview
 Table 117. Otsuka Pharmaceutical Co. Ltd. Delirium Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Otsuka Pharmaceutical Co. Ltd. Delirium Treatment Drugs Product
 Table 119. Otsuka Pharmaceutical Co. Ltd. Recent Developments/Updates
 Table 120. Zydus Cadila Company Information
 Table 121. Zydus Cadila Description and Business Overview
 Table 122. Zydus Cadila Delirium Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Zydus Cadila Delirium Treatment Drugs Product
 Table 124. Zydus Cadila Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Delirium Treatment Drugs Distributors List
 Table 128. Delirium Treatment Drugs Customers List
 Table 129. Delirium Treatment Drugs Market Trends
 Table 130. Delirium Treatment Drugs Market Drivers
 Table 131. Delirium Treatment Drugs Market Challenges
 Table 132. Delirium Treatment Drugs Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Delirium Treatment Drugs
 Figure 2. Global Delirium Treatment Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Delirium Treatment Drugs Market Share by Type: 2024 & 2031
 Figure 4. Oral Product Picture
 Figure 5. Injection Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Delirium Treatment Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Delirium Treatment Drugs Market Share by Application: 2024 & 2031
 Figure 9. Hospitals
 Figure 10. Clinics
 Figure 11. Global Delirium Treatment Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Delirium Treatment Drugs Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Delirium Treatment Drugs Sales (2020-2031) & (K Units)
 Figure 14. Global Delirium Treatment Drugs Average Price (US$/Unit) & (2020-2031)
 Figure 15. Delirium Treatment Drugs Report Years Considered
 Figure 16. Delirium Treatment Drugs Sales Share by Manufacturers in 2024
 Figure 17. Global Delirium Treatment Drugs Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Delirium Treatment Drugs Players: Market Share by Revenue in Delirium Treatment Drugs in 2024
 Figure 19. Delirium Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Delirium Treatment Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Delirium Treatment Drugs Sales Market Share by Country (2020-2031)
 Figure 22. North America Delirium Treatment Drugs Revenue Market Share by Country (2020-2031)
 Figure 23. United States Delirium Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Delirium Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Delirium Treatment Drugs Sales Market Share by Country (2020-2031)
 Figure 26. Europe Delirium Treatment Drugs Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Delirium Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Delirium Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Delirium Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Delirium Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Delirium Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Delirium Treatment Drugs Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Delirium Treatment Drugs Revenue Market Share by Region (2020-2031)
 Figure 34. China Delirium Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Delirium Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Delirium Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Delirium Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Delirium Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Delirium Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Delirium Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Delirium Treatment Drugs Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Delirium Treatment Drugs Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Delirium Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Delirium Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Delirium Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Delirium Treatment Drugs Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Delirium Treatment Drugs Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Delirium Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Delirium Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Delirium Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Delirium Treatment Drugs by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Delirium Treatment Drugs by Type (2020-2031)
 Figure 53. Global Delirium Treatment Drugs Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Delirium Treatment Drugs by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Delirium Treatment Drugs by Application (2020-2031)
 Figure 56. Global Delirium Treatment Drugs Price (US$/Unit) by Application (2020-2031)
 Figure 57. Delirium Treatment Drugs Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String